Users who fail to migrate their accounts before quantum computers become a practical threat would not automatically lose their assets under Circle’s new plan —Users who fail to migrate their accounts before quantum computers become a practical threat would not automatically lose their assets under Circle’s new plan —

Circle Targets Post-Quantum Security In Bold USDC Roadmap

2026/06/01 09:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Users who fail to migrate their accounts before quantum computers become a practical threat would not automatically lose their assets under Circle’s new plan — the company is proposing recovery frameworks tied to cryptographic proofs, seed phrase verification, exchange records, and even court orders if necessary.

A Long Road, Not A Quick Fix

Circle, which issues the USDC stablecoin across more than 30 blockchain networks, published a post-quantum security whitepaper on Friday outlining how it intends to prepare USDC and its upcoming Arc blockchain for an era when today’s cryptographic standards may no longer hold.

The plan runs in three phases: a readiness stage to identify vulnerable systems, a transition period where old and new cryptography operate side by side, and a final migration that could see classical signature schemes retired entirely.

The underlying risk is technical but significant. Most blockchains rely on elliptic curve cryptography, and a powerful enough quantum computer running Shor’s algorithm could theoretically extract private keys from public keys — a scenario Circle describes as a potential “cliff event” rather than a slow-building threat.

The company was quick to add that conventional cybersecurity risks remain the more immediate concern, and that no firm timeline exists for when quantum machines capable of breaking current encryption might arrive.

The Immutable Contract Problem

Arc, Circle’s forthcoming blockchain, is set to launch with several protections already built in. Reports say it will support SLH-DSA signatures — a hash-based standard designed to withstand quantum attacks — along with post-quantum encrypted communications using HPKE and X-Wing technologies.

Privacy on the network will be handled through trusted execution environments, including AWS Nitro Enclaves, which process encrypted transactions and shield balance data from outside view.

Upgrading existing USDC smart contracts presents a harder challenge. Circle plans to modify contracts that allow upgrades so they can accept both traditional and post-quantum signatures at the same time, letting users migrate at their own pace.

But immutable contracts are a different story — particularly Ethereum’s widely used “ecrecover” function, which is baked into countless deployed contracts that cannot be changed. According to Circle, protocol-level intervention may be the only path forward there.

Regulatory Questions Left Open

The account recovery proposals are among the more forward-looking parts of the whitepaper. Circle also flagged longer-term risks around blockchain history itself, warning that compromised validator keys on proof-of-stake networks could potentially be used to tamper with historical records.

To counter that, the roadmap calls for validator migration, post-quantum-secured checkpoints, and mechanisms to validate chain history going forward.

Featured image from Unsplash, chart from TradingView

Market Opportunity
USDCoin Logo
USDCoin Price(USDC)
$1.00088
$1.00088$1.00088
-0.01%
USD
USDCoin (USDC) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage